Mechanism of DAPK1 for Regulating Cancer Stem Cells in Thyroid Cancer

Mi-Hyeon You1

  • 1Department of Anatomy, Konkuk University College of Medicine, 50-1, 268 Chungwon-daero, Cungju-si 27478, Republic of Korea.

Insights

Death-associated protein kinase 1 (DAPK1) is downregulated in metastatic cancers. This review explores DAPK1's role in regulating cancer stem cells (CSCs) and epithelial-mesenchymal transition (EMT) in papillary thyroid carcinoma (PTC) progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Death-associated protein kinase 1 (DAPK1) is a serine/threonine kinase downregulated in metastatic cancers.
  • DAPK1 regulates tumor suppression, epithelial-mesenchymal transition (EMT), and cancer stem cell (CSC) formation.
  • The role of DAPK1 in CSC regulation within papillary thyroid carcinoma (PTC) remains largely unelucidated.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which DAPK1 regulates CSCs in PTC progression.
  • To review the current understanding of DAPK1's involvement in thyroid cancer, specifically PTC.
  • To highlight the link between DAPK1, EMT, and CSCs in the context of PTC.

Main Methods:

  • Literature review of studies on DAPK1, CSCs, and EMT in cancer.
  • Analysis of epigenetic, transcriptional, posttranscriptional, and posttranslational regulation of DAPK1.
  • Synthesis of existing data to propose a model for DAPK1-mediated CSC regulation in PTC.

Main Results:

  • DAPK1 downregulation is implicated in cancer progression through various regulatory mechanisms.
  • DAPK1 influences both cancer and stromal cells, impacting tumor behavior.
  • Emerging evidence suggests DAPK1's critical role in EMT and CSC generation in thyroid cancers.

Conclusions:

  • DAPK1 plays a multifaceted role in cancer, including tumor suppression and promotion of EMT and CSCs.
  • Understanding DAPK1's regulation of CSCs in PTC is crucial for developing targeted therapies.
  • Further research is needed to fully delineate the molecular pathways involved in DAPK1-mediated CSC regulation in PTC.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K